Benefits of Sulforaphane

Evidence-Based Benefits

• Nrf2 activation — sulforaphane is the most potent dietary activator of Nrf2, the transcription factor that upregulates over 200 cytoprotective genes including glutathione synthesis (GSH), NAD(P)H quinone oxidoreductase (NQO1), and heme oxygenase-1 (HO-1)
• Detoxification — Egner et al. (2014) conducted an RCT in Qidong, China, showing broccoli sprout beverage significantly enhanced excretion of benzene (61% increase) and acrolein (23% increase) — two carcinogenic air pollutants
• Anti-inflammatory — sulforaphane inhibits NF-κB activation and reduces inflammatory markers; a 2018 study by Mazarakis et al. showed reduced systemic inflammation in human volunteers consuming broccoli sprout extract
• Cancer chemoprevention — a Johns Hopkins RCT by Atwell et al. (2015) showed sulforaphane-rich broccoli sprout extract modulated HDAC activity and cell cycle progression markers in breast cancer patients
• Blood sugar support — Axelsson et al. (2017) published in Science Translational Medicine that sulforaphane reduced fasting blood glucose by 10% in obese type 2 diabetes patients with dysregulated glucose control

What the Research Says

Sulforaphane is a bioactive compound derived from cruciferous vegetables such as broccoli and Brussels sprouts. It exerts its health benefits through activation of the Nrf2 pathway, which enhances antioxidant defenses and detoxification processes (Talalay et al., 1992). A randomized controlled trial by Egner et al. (2014) demonstrated that sulforaphane, administered as a broccoli sprout beverage, significantly increased the excretion of airborne pollutants in a Chinese population, underscoring its potential role in detoxification support.

Recent studies have explored sulforaphane's therapeutic applications across various conditions. Axelsson et al. (2017) found that sulforaphane improves blood sugar control in individuals with type 2 diabetes by reducing hepatic glucose production. Additionally, Guo et al. (2025) conducted a meta-analysis of five studies involving 129 patients with autism spectrum disorder (ASD), revealing significant improvements in irritability and hyperactivity symptoms, suggesting sulforaphane as a potential complementary treatment.

The bioavailability of sulforaphane is influenced by its formulation. Products containing both glucoraphanin and myrosinase, or stabilized pre-formed sulforaphane, are preferred due to the enzyme's role in converting glucoraphanin into active sulforaphane (Conzatti et al., 2014). Home cultivation of broccoli sprouts is also a cost-effective method for obtaining sulforaphane.

Related Conditions